HEMOGENYX
HemoGenyx LLC, a privately held biopharmaceutical company, is developing a revolutionary new treatment for blood diseases, such as leukemia and lymphoma. They leverage a special class of cells, which can generate cancer-free blood stem cells. Their therapy will dramatically increase the efficacy of bone marrow transplants and eliminate the need for donors.
HEMOGENYX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.hemogenyx.com
Total Employee:
11+
Status:
Active
Contact:
+1 (347) 735-8380
Email Addresses:
[email protected]
Total Funding:
61.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Mint Capital
Mint Capital investment in Post-IPO Debt - HemoGenyx
43North
43North investment in Seed Round - HemoGenyx
Official Site Inspections
http://www.hemogenyx.com
- Host name: li677-21.members.linode.com
- IP address: 88.80.184.21
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V